Orbimed Advisors LLC Compass Therapeutics, Inc. Transaction History
Orbimed Advisors LLC
- $4.44 Billion
- Q1 2024
A detailed history of Orbimed Advisors LLC transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 22,362,850 shares of CMPX stock, worth $23.7 Million. This represents 1.0% of its overall portfolio holdings.
Number of Shares
22,362,850
Previous 22,362,850
-0.0%
Holding current value
$23.7 Million
Previous $34.9 Million
26.92%
% of portfolio
1.0%
Previous 0.85%
Shares
3 transactions
Others Institutions Holding CMPX
# of Institutions
80Shares Held
94.2MCall Options Held
0Put Options Held
0-
Adage Capital Partners Gp, L.L.C. Boston, MA11.1MShares$11.8 Million0.04% of portfolio
-
Janus Henderson Group PLC London, X06.49MShares$6.88 Million0.01% of portfolio
-
Blackstone Inc New York, NY6.19MShares$6.56 Million0.05% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$6.39 Million0.0% of portfolio
-
Cormorant Asset Management, LP Boston, MA5.56MShares$5.89 Million0.63% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $107M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...